167 related articles for article (PubMed ID: 37592236)
21. Assessment of bone marrow lymphocytic status during tyrosine kinase inhibitor therapy and its relation to therapy response in chronic myeloid leukaemia.
El Missiry M; Adnan Awad S; Rajala HL; Al-Samadi A; Ekblom M; Markevän B; Åstrand-Grundström I; Wold M; Svedahl ER; Juhl BR; Bjerrum OW; Haulin I; Porkka K; Olsson-Strömberg U; Hjorth-Hansen H; Mustjoki S
J Cancer Res Clin Oncol; 2016 May; 142(5):1041-50. PubMed ID: 26746653
[TBL] [Abstract][Full Text] [Related]
22. Chronic Co-Administration of Sepiapterin and L-Citrulline Ameliorates Diabetic Cardiomyopathy and Myocardial Ischemia/Reperfusion Injury in Obese Type 2 Diabetic Mice.
Baumgardt SL; Paterson M; Leucker TM; Fang J; Zhang DX; Bosnjak ZJ; Warltier DC; Kersten JR; Ge ZD
Circ Heart Fail; 2016 Jan; 9(1):e002424. PubMed ID: 26763290
[TBL] [Abstract][Full Text] [Related]
23. Comparison of the antidiabetic effects of brain-derived neurotrophic factor and thiazolidinediones in obese diabetic mice.
Yamanaka M; Itakura Y; Tsuchida A; Nakagawa T; Noguchi H; Taiji M
Diabetes Obes Metab; 2007 Nov; 9(6):879-88. PubMed ID: 17924870
[TBL] [Abstract][Full Text] [Related]
24. Activating Adenosine Monophosphate-Activated Protein Kinase Mediates Fibroblast Growth Factor 1 Protection From Nonalcoholic Fatty Liver Disease in Mice.
Lin Q; Huang Z; Cai G; Fan X; Yan X; Liu Z; Zhao Z; Li J; Li J; Shi H; Kong M; Zheng MH; Conklin DJ; Epstein PN; Wintergerst KA; Mohammadi M; Cai L; Li X; Li Y; Tan Y
Hepatology; 2021 Jun; 73(6):2206-2222. PubMed ID: 32965675
[TBL] [Abstract][Full Text] [Related]
25. Can Dasatinib Ameliorate the Hepatic changes, Induced by Long Term Western Diet, in Mice?
Elsayed HRH; El-Nablaway M; Othman BH; Abdalla AM; El Nashar EM; Abd-Elmonem MM; El-Gamal R
Ann Anat; 2021 Mar; 234():151626. PubMed ID: 33144268
[TBL] [Abstract][Full Text] [Related]
26. Human Umbilical Cord-Derived Mesenchymal Stem Cell Therapy Ameliorates Nonalcoholic Fatty Liver Disease in Obese Type 2 Diabetic Mice.
Li B; Cheng Y; Yu S; Zang L; Yin Y; Liu J; Zhang L; Mu Y
Stem Cells Int; 2019; 2019():8628027. PubMed ID: 31781248
[TBL] [Abstract][Full Text] [Related]
27. Dasatinib Attenuates Pressure Overload Induced Cardiac Fibrosis in a Murine Transverse Aortic Constriction Model.
Balasubramanian S; Pleasant DL; Kasiganesan H; Quinones L; Zhang Y; Sundararaj KP; Roche S; O'Connor R; Bradshaw AD; Kuppuswamy D
PLoS One; 2015; 10(10):e0140273. PubMed ID: 26458186
[TBL] [Abstract][Full Text] [Related]
28. Association of non-alcoholic steatohepatitis with subclinical myocardial dysfunction in non-cirrhotic patients.
Lee YH; Kim KJ; Yoo ME; Kim G; Yoon HJ; Jo K; Youn JC; Yun M; Park JY; Shim CY; Lee BW; Kang SM; Ha JW; Cha BS; Kang ES
J Hepatol; 2018 Apr; 68(4):764-772. PubMed ID: 29175242
[TBL] [Abstract][Full Text] [Related]
29. Eplerenone attenuated cardiac steatosis, apoptosis and diastolic dysfunction in experimental type-II diabetes.
Ramírez E; Klett-Mingo M; Ares-Carrasco S; Picatoste B; Ferrarini A; Rupérez FJ; Caro-Vadillo A; Barbas C; Egido J; Tuñón J; Lorenzo Ó
Cardiovasc Diabetol; 2013 Nov; 12():172. PubMed ID: 24261558
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of PKC-θ preserves cardiac function and reduces fibrosis in streptozotocin-induced diabetic cardiomyopathy.
Li Z; Abdullah CS; Jin ZQ
Br J Pharmacol; 2014 Jun; 171(11):2913-24. PubMed ID: 24641494
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of JNK by novel curcumin analog C66 prevents diabetic cardiomyopathy with a preservation of cardiac metallothionein expression.
Wang Y; Zhou S; Sun W; McClung K; Pan Y; Liang G; Tan Y; Zhao Y; Liu Q; Sun J; Cai L
Am J Physiol Endocrinol Metab; 2014 Jun; 306(11):E1239-47. PubMed ID: 24714399
[TBL] [Abstract][Full Text] [Related]
32. A novel dual PPAR-γ agonist/sEH inhibitor treats diabetic complications in a rat model of type 2 diabetes.
Hye Khan MA; Kolb L; Skibba M; Hartmann M; Blöcher R; Proschak E; Imig JD
Diabetologia; 2018 Oct; 61(10):2235-2246. PubMed ID: 30032428
[TBL] [Abstract][Full Text] [Related]
33. Iron aggravates hepatic insulin resistance in the absence of inflammation in a novel db/db mouse model with iron overload.
Altamura S; Müdder K; Schlotterer A; Fleming T; Heidenreich E; Qiu R; Hammes HP; Nawroth P; Muckenthaler MU
Mol Metab; 2021 Sep; 51():101235. PubMed ID: 33872860
[TBL] [Abstract][Full Text] [Related]
34. Nerve growth factor gene therapy improves bone marrow sensory innervation and nociceptor-mediated stem cell release in a mouse model of type 1 diabetes with limb ischaemia.
Dang Z; Avolio E; Albertario A; Sala-Newby GB; Thomas AC; Wang N; Emanueli C; Madeddu P
Diabetologia; 2019 Jul; 62(7):1297-1311. PubMed ID: 31016359
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of Sitagliptin on Nonalcoholic Fatty Liver Disease in High-fat-diet-fed Diabetic Mice.
Zhou ST; Cui W; Kong L; Yang X
Curr Med Sci; 2022 Jun; 42(3):513-519. PubMed ID: 35451807
[TBL] [Abstract][Full Text] [Related]
36. FNDC5/Irisin attenuates diabetic cardiomyopathy in a type 2 diabetes mouse model by activation of integrin αV/β5-AKT signaling and reduction of oxidative/nitrosative stress.
Lin C; Guo Y; Xia Y; Li C; Xu X; Qi T; Zhang F; Fan M; Hu G; Zhao H; Zhao H; Liu R; Gao E; Yan W; Tao L
J Mol Cell Cardiol; 2021 Nov; 160():27-41. PubMed ID: 34224725
[TBL] [Abstract][Full Text] [Related]
37. Combination therapy with pioglitazone/exenatide/metformin reduces the prevalence of hepatic fibrosis and steatosis: The efficacy and durability of initial combination therapy for type 2 diabetes (EDICT).
Lavynenko O; Abdul-Ghani M; Alatrach M; Puckett C; Adams J; Abdelgani S; Alkhouri N; Triplitt C; Clarke GD; Vasquez JA; Li J; Cersosimo E; Gastaldelli A; DeFronzo RA
Diabetes Obes Metab; 2022 May; 24(5):899-907. PubMed ID: 35014145
[TBL] [Abstract][Full Text] [Related]
38. Angiotensin 1-7 ameliorates diabetic cardiomyopathy and diastolic dysfunction in db/db mice by reducing lipotoxicity and inflammation.
Mori J; Patel VB; Abo Alrob O; Basu R; Altamimi T; Desaulniers J; Wagg CS; Kassiri Z; Lopaschuk GD; Oudit GY
Circ Heart Fail; 2014 Mar; 7(2):327-39. PubMed ID: 24389129
[TBL] [Abstract][Full Text] [Related]
39. Retinoic acid receptor β2 agonists restore glycaemic control in diabetes and reduce steatosis.
Trasino SE; Tang XH; Jessurun J; Gudas LJ
Diabetes Obes Metab; 2016 Feb; 18(2):142-51. PubMed ID: 26462866
[TBL] [Abstract][Full Text] [Related]
40. Comparison of adipose tissue- and bone marrow- derived mesenchymal stem cells for alleviating doxorubicin-induced cardiac dysfunction in diabetic rats.
Ammar HI; Sequiera GL; Nashed MB; Ammar RI; Gabr HM; Elsayed HE; Sareen N; Rub EA; Zickri MB; Dhingra S
Stem Cell Res Ther; 2015 Aug; 6(1):148. PubMed ID: 26296856
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]